Piedmont Lithium Inc. - Quarter Report: 2023 September (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
FORM 10-Q
________________________________
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2023
OR
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _______ to ________
Commission File Number 001-38427
___________________________________________________________
Piedmont Lithium Inc.
(Exact name of Registrant as specified in its Charter)
_________________________________________________________________________________________
Delaware | 36-4996461 | ||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
42 E Catawba Street Belmont, North Carolina | 28012 | ||||
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (704) 461-8000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Common stock, $0.0001 par value per share | PLL | The Nasdaq Capital Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (“Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☒ | Accelerated filer | ☐ | Emerging growth company | ☐ | ||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of November 03, 2023, there were 19,209,327 shares of the Registrant’s common stock outstanding.
1
Table of Contents
Page | |||||||||||
Glossary of Terms and Definitions | |||||||||||
PART I - Financial Information | |||||||||||
PART II - Other Information | |||||||||||
Item 1A. | |||||||||||
2
GLOSSARY OF TERMS AND DEFINITIONS
When the following terms and abbreviations appear in the text of this report, they have the meanings indicated below:
Air Permit | Conditional Major Non-Title V Construction and Operating Air Permit | ||||
ASX | Australian Securities Exchange | ||||
Atlantic Lithium | Atlantic Lithium Limited | ||||
Atlantic Lithium Ghana | Atlantic Lithium’s Ghanaian-based lithium portfolio companies | ||||
ATVM | Advanced Technology Vehicles Manufacturing Loan Program | ||||
Benton Resources | Benton Resources Inc. | ||||
Carolina Lithium | The Carolina Lithium project is Piedmont Lithium’s planned, integrated spodumene-to-lithium hydroxide project located within the renowned Carolina Tin Spodumene Belt in Gaston County, North Carolina | ||||
CODM | Chief Operating Decision Maker | ||||
DEMLR | Department of Energy, Mineral and Land Resources | ||||
DFS | Definitive feasibility study | ||||
dmt | Dry metric ton | ||||
DOE | U.S. Department of Energy | ||||
Ewoyaa | The Ewoyaa Lithium Project is the flagship project of Atlantic Lithium Ghana located in the Cape Coast region of West Africa, Ghana | ||||
Exchange Act | Securities Exchange Act of 1934 | ||||
FDIC | Federal Deposit Insurance Corporation | ||||
Incentive Plan | Piedmont Lithium Inc. Stock Incentive Plan | ||||
LG Chem | LG Chem, Ltd. | ||||
Li2O | Lithium oxide | ||||
MIIF | Minerals Income Investment Fund of Ghana | ||||
Milestone PRAs | PRAs that could be earned based upon achievement of certain specified milestones | ||||
NAL | North American Lithium Inc. | ||||
NCDEQ | North Carolina Department of Environmental Quality | ||||
Piedmont Lithium Inc. | “Piedmont Lithium,” “we,” “our,” “us,” or “Company” | ||||
PRAs | Performance rights awards | ||||
Ricca | Ricca Resources Limited | ||||
RSUs | Restricted stock units | ||||
Sayona Mining | Sayona Mining Limited | ||||
Sayona Quebec | Sayona Quebec Inc. | ||||
SEC | Securities and Exchange Commission | ||||
Sokoman Minerals | Sokoman Minerals Corp. | ||||
spodumene concentrate | Spodumene concentrate or SC[X] where “X” represents the lithium content of the concentrate on an Li2O% basis | ||||
TDEC | Tennessee Department of Environment and Conservation | ||||
Tennessee Lithium | The Tennessee Lithium project is Piedmont Lithium’s planned 30,000 tons per year lithium hydroxide conversion facility project located in Etowah, Tennessee | ||||
TSR PRAs | PRAs related to market goals based on a comparison of the Company's total shareholder return relative to the total shareholder return of a pre-determined set of peer group companies for the performance periods | ||||
U.S. | United States of America | ||||
U.S. GAAP | U.S. Generally Accepted Accounting Principles | ||||
Vinland Lithium | Vinland Lithium Inc. |
3
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
PIEDMONT LITHIUM INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts) (Unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Revenue | $ | 47,127 | $ | — | $ | 47,127 | $ | — | ||||||||||||||||||
Costs of sales | 23,363 | — | 23,363 | — | ||||||||||||||||||||||
Gross profit | 23,764 | — | 23,764 | — | ||||||||||||||||||||||
Exploration and mine development costs | 471 | 434 | 1,668 | 1,485 | ||||||||||||||||||||||
Selling, general, and administrative expenses | 11,185 | 7,160 | 31,793 | 20,200 | ||||||||||||||||||||||
Total operating expenses | 11,656 | 7,594 | 33,461 | 21,685 | ||||||||||||||||||||||
Income (loss) from equity method investments(1) | 3,852 | (2,003) | (1,565) | (6,547) | ||||||||||||||||||||||
Income (loss) from operations | 15,960 | (9,597) | (11,262) | (28,232) | ||||||||||||||||||||||
Interest income | 1,031 | 373 | 2,959 | 373 | ||||||||||||||||||||||
Interest expense | (8) | (21) | (34) | (97) | ||||||||||||||||||||||
Loss from foreign currency exchange | (22) | (35) | (88) | (60) | ||||||||||||||||||||||
Gain on dilution of equity method investments(1) | 7,958 | 29,367 | 15,208 | 29,367 | ||||||||||||||||||||||
Total other income | 8,959 | 29,684 | 18,045 | 29,583 | ||||||||||||||||||||||
Income before taxes | 24,919 | 20,087 | 6,783 | 1,351 | ||||||||||||||||||||||
Income tax expense | 2,028 | 3,422 | 3,170 | 3,422 | ||||||||||||||||||||||
Net income (loss) | $ | 22,891 | $ | 16,665 | $ | 3,613 | $ | (2,071) | ||||||||||||||||||
Earnings (loss) per share: | ||||||||||||||||||||||||||
Basic | $ | 1.19 | $ | 0.93 | $ | 0.19 | $ | (0.12) | ||||||||||||||||||
Diluted | $ | 1.19 | $ | 0.92 | $ | 0.19 | $ | (0.12) | ||||||||||||||||||
Weighted-average shares outstanding | ||||||||||||||||||||||||||
Basic | 19,203 | 17,966 | 18,974 | 17,343 | ||||||||||||||||||||||
Diluted | 19,239 | 18,081 | 19,011 | 17,343 |
__________________________
(1)Income (loss) from equity method investments and Gain on dilution of equity method investments are reported on a one-quarter lag.
The accompanying notes are an integral part of these unaudited financial statements.
4
PIEDMONT LITHIUM INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands) (Unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Net Income (loss) | $ | 22,891 | $ | 16,665 | $ | 3,613 | $ | (2,071) | ||||||||||||||||||
Other comprehensive income (loss), net of tax: | ||||||||||||||||||||||||||
Foreign currency translation adjustment of equity method investments(1) | (2,992) | 811 | (4,084) | 662 | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax | (2,992) | 811 | (4,084) | 662 | ||||||||||||||||||||||
Comprehensive income (loss) | $ | 19,899 | $ | 17,476 | $ | (471) | $ | (1,409) |
__________________________
(1)Foreign currency translation adjustment of equity method investments is presented net of tax (expense) benefit of $264 and $(392) for the three months ended September 30, 2023, and 2022 respectively, and $830 and $(392) for the nine months ended September 30, 2023, and 2022 respectively.
The accompanying notes are an integral part of these unaudited financial statements.
5
PIEDMONT LITHIUM INC.
CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited) | |||||||||||
September 30, 2023 | December 31, 2022 | ||||||||||
Assets | |||||||||||
Cash and cash equivalents | $ | 94,495 | $ | 99,247 | |||||||
Accounts receivable | 23,281 | — | |||||||||
Other current assets | 4,374 | 2,612 | |||||||||
Total current assets | 122,150 | 101,859 | |||||||||
Property, plant and mine development, net | 116,422 | 71,541 | |||||||||
Other non-current assets | 25,734 | 18,873 | |||||||||
Equity method investments | 133,044 | 95,648 | |||||||||
Total assets | $ | 397,350 | $ | 287,921 | |||||||
Liabilities and Stockholders’ Equity | |||||||||||
Accounts payable and accrued expenses | $ | 34,607 | $ | 12,862 | |||||||
Current portion of long-term debt | 201 | 425 | |||||||||
Other current liabilities | 8,052 | 124 | |||||||||
Total current liabilities | 42,860 | 13,411 | |||||||||
Long-term debt, net of current portion | 44 | 163 | |||||||||
Operating lease liabilities, net of current portion | 1,174 | 1,177 | |||||||||
Deferred tax liabilities | 5,221 | 2,881 | |||||||||
Total liabilities | 49,299 | 17,632 | |||||||||
Commitments and contingencies (Note 12) | |||||||||||
Stockholders’ equity: | |||||||||||
Common stock; $0.0001 par value, 100,000 shares authorized; 19,209 and 18,073 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively | 2 | 2 | |||||||||
Additional paid-in capital | 459,475 | 381,242 | |||||||||
Accumulated deficit | (102,045) | (105,658) | |||||||||
Accumulated other comprehensive loss | (9,381) | (5,297) | |||||||||
Total stockholders’ equity | 348,051 | 270,289 | |||||||||
Total liabilities and stockholders’ equity | $ | 397,350 | $ | 287,921 |
The accompanying notes are an integral part of these unaudited financial statements.
6
PIEDMONT LITHIUM INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands) (Unaudited)
Nine Months Ended September 30, | |||||||||||
2023 | 2022 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net Income (loss) | $ | 3,613 | $ | (2,071) | |||||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||||||||
Stock-based compensation expense | 7,378 | 2,643 | |||||||||
Loss from equity method investments | 1,565 | 6,547 | |||||||||
Gain on dilution of equity method investments | (15,208) | (29,367) | |||||||||
Deferred taxes | 3,170 | 3,422 | |||||||||
Depreciation | 174 | 32 | |||||||||
Noncash lease expense | 169 | 72 | |||||||||
Loss on sale of property, plant and mine development | — | 12 | |||||||||
Unrealized loss on investment | 27 | 54 | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | (23,281) | — | |||||||||
Other assets | (1,633) | (959) | |||||||||
Operating lease liabilities | (148) | (69) | |||||||||
Accounts payable | 21,865 | 270 | |||||||||
Accrued expenses and other current liabilities | 7,712 | (2,627) | |||||||||
Net cash provided by (used in) operating activities | 5,403 | (22,041) | |||||||||
Cash flows from investing activities: | |||||||||||
Capital expenditures | (44,978) | (21,892) | |||||||||
Advances to affiliates | (6,828) | (9,815) | |||||||||
Investments in equity method investments | (28,667) | (14,087) | |||||||||
Net cash used in investing activities | (80,473) | (45,794) | |||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from issuances of common stock, net of issuance costs | 71,084 | 122,059 | |||||||||
Proceeds from exercise of stock options | — | 93 | |||||||||
Principal payments on long-term debt | (344) | (973) | |||||||||
Payments to tax authorities for employee stock-based compensation | (422) | — | |||||||||
Net cash provided by financing activities | 70,318 | 121,179 | |||||||||
Net (decrease) increase in cash | (4,752) | 53,344 | |||||||||
Cash and cash equivalents at beginning of period | 99,247 | 64,245 | |||||||||
Cash and cash equivalents at end of period | $ | 94,495 | $ | 117,589 | |||||||
Supplemental disclosure of cash flow information: | |||||||||||
Noncash capital expenditures in accounts payable and accrued expenses | $ | 5,114 | $ | 2,227 | |||||||
Cash paid for interest | 34 | 97 | |||||||||
Capitalized stock-based compensation | 193 | 213 | |||||||||
The accompanying notes are an integral part of these unaudited financial statements.
7
PIEDMONT LITHIUM INC.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(In thousands) (Unaudited)
Common Stock | Additional Paid-In Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||||||||
December 31, 2022 | 18,073 | $ | 2 | $ | 381,242 | $ | (105,658) | $ | (5,297) | $ | 270,289 | ||||||||||||||||||||||||
Issuance of common stock, net | 1,097 | — | 71,084 | — | — | 71,084 | |||||||||||||||||||||||||||||
Stock-based compensation, net of forfeitures | — | — | 1,166 | — | — | 1,166 | |||||||||||||||||||||||||||||
Shares issued for exercise/vesting of share-based compensation awards | 13 | — | — | — | — | — | |||||||||||||||||||||||||||||
Equity method investment adjustments in other comprehensive loss, net of tax | — | — | — | — | (2,213) | (2,213) | |||||||||||||||||||||||||||||
Net loss | — | — | — | (8,639) | — | (8,639) | |||||||||||||||||||||||||||||
March 31, 2023 | 19,183 | $ | 2 | $ | 453,492 | $ | (114,297) | $ | (7,510) | $ | 331,687 | ||||||||||||||||||||||||
Stock-based compensation, net of forfeitures | — | — | 3,266 | — | — | 3,266 | |||||||||||||||||||||||||||||
Shares issued for exercise/vesting of share-based compensation awards | 13 | — | — | — | — | — | |||||||||||||||||||||||||||||
Equity method investment adjustments in other comprehensive income, net of tax | — | — | — | — | 1,121 | 1,121 | |||||||||||||||||||||||||||||
Net loss | — | — | — | (10,639) | — | (10,639) | |||||||||||||||||||||||||||||
June 30, 2023 | 19,196 | $ | 2 | $ | 456,758 | $ | (124,936) | $ | (6,389) | $ | 325,435 | ||||||||||||||||||||||||
Stock-based compensation, net of forfeitures | — | — | 3,139 | — | — | 3,139 | |||||||||||||||||||||||||||||
Shares issued for exercise/vesting of share-based compensation awards | 24 | — | — | — | — | — | |||||||||||||||||||||||||||||
Shares surrendered for tax obligations for share-based transactions | (11) | — | (422) | — | — | (422) | |||||||||||||||||||||||||||||
Equity method investment adjustments in other comprehensive income (loss), net of tax | — | — | — | — | (2,992) | (2,992) | |||||||||||||||||||||||||||||
Net income | — | — | — | 22,891 | — | 22,891 | |||||||||||||||||||||||||||||
September 30, 2023 | 19,209 | $ | 2 | $ | 459,475 | $ | (102,045) | $ | (9,381) | $ | 348,051 |
The accompanying notes are an integral part of these unaudited financial statements.
8
PIEDMONT LITHIUM INC.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(In thousands)(Unaudited)
Common Stock | Additional Paid-In Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||||||||
December 31, 2021 | 15,894 | $ | 2 | $ | 255,132 | $ | (92,683) | $ | (666) | $ | 161,785 | ||||||||||||||||||||||||
Issuance of common stock, net | 2,013 | — | 122,059 | — | — | 122,059 | |||||||||||||||||||||||||||||
Stock-based compensation, net of forfeitures | — | — | (86) | — | — | (86) | |||||||||||||||||||||||||||||
Shares issued for exercise/vesting of share-based compensation awards | 23 | — | — | — | — | — | |||||||||||||||||||||||||||||
Equity method investment adjustments in other comprehensive income, net of tax | — | — | — | — | 194 | 194 | |||||||||||||||||||||||||||||
Net loss | — | — | — | (9,155) | — | (9,155) | |||||||||||||||||||||||||||||
March 31, 2022 | 17,930 | $ | 2 | $ | 377,105 | $ | (101,838) | $ | (472) | $ | 274,797 | ||||||||||||||||||||||||
Stock-based compensation, net of forfeitures | — | — | 1,591 | — | — | 1,591 | |||||||||||||||||||||||||||||
Shares issued for exercise/vesting of share-based compensation awards | 35 | — | 94 | — | — | 93 | |||||||||||||||||||||||||||||
Equity method investment adjustments in other comprehensive loss, net of tax | — | — | — | — | (343) | (343) | |||||||||||||||||||||||||||||
Net loss | — | — | — | (9,581) | — | (9,581) | |||||||||||||||||||||||||||||
June 30, 2022 | 17,965 | $ | 2 | $ | 378,790 | $ | (111,419) | $ | (815) | $ | 266,558 | ||||||||||||||||||||||||
Stock-based compensation, net of forfeitures | — | — | 1,350 | — | — | 1,350 | |||||||||||||||||||||||||||||
Shares issued for exercise/vesting of share-based compensation awards | 30 | — | — | — | — | — | |||||||||||||||||||||||||||||
Equity method investment adjustments in other comprehensive income, net of tax | — | — | — | — | 811 | 811 | |||||||||||||||||||||||||||||
Net income | — | — | — | 16,665 | — | 16,665 | |||||||||||||||||||||||||||||
September 30, 2022 | 17,995 | $ | 2 | $ | 380,140 | $ | (94,754) | $ | (4) | $ | 285,384 |
The accompanying notes are an integral part of these unaudited financial statements.
9
PIEDMONT LITHIUM INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1.DESCRIPTION OF COMPANY
Nature of Business
Piedmont Lithium Inc. (“Piedmont Lithium,” “we,” “our,” “us,” or “Company”) is a U.S. based, development-stage, multi-asset, integrated lithium business in support of a clean energy economy and U.S. and global energy security. We plan to supply lithium hydroxide to the electric vehicle and battery manufacturing supply chains in North America by processing spodumene concentrate produced from assets we own or in which we have an economic interest.
Our portfolio of wholly owned projects includes Tennessee Lithium, a proposed merchant lithium hydroxide manufacturing plant in McMinn County, Tennessee, and Carolina Lithium, a proposed, fully integrated spodumene concentrate-to-lithium hydroxide project in Gaston County, North Carolina. The balance of our project portfolio includes strategic investments in lithium assets in Quebec, Canada, including the operating NAL mine, and in Ghana, West Africa with Atlantic Lithium, including Ewoyaa.
Basis of Presentation
Our unaudited consolidated financial statements and related notes have been prepared on the accrual basis of accounting in conformity with U.S. GAAP and in conformity with the rules and regulations of the SEC. The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Our reporting currency is U.S. dollars, and we operate on a calendar fiscal year. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our amended Annual Report on Form 10-K/A for the year ended December 31, 2022. These unaudited consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are considered necessary for a fair statement of the results of operations, financial position, and cash flows for the periods presented. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the year ending December 31, 2023, for any other interim period, or for any other future fiscal year.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments, provisional revenue adjustments, collectability of receivables and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.
We base our estimates and assumptions on current facts, historical experience, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between estimates and actual results, future results of operations will be affected.
Risk and Uncertainties
We are subject to a number of risks similar to those of other companies of similar size in our industry, including but not limited to, the success of our exploration and development activities, success of our equity method investments in international projects, permitting and construction delays, the need for additional capital or financing to fund operating losses, competition from substitute products and services, protection of proprietary technology, litigation, and dependence on key individuals.
We have accumulated deficits of $102.0 million and $105.7 million as of September 30, 2023 and December 31, 2022, respectively. We have cash available on hand and believe this cash will be sufficient to fund our operations and meet our obligations as they come due for at least one year from the date these unaudited consolidated financial statements are issued. In the event our cash requirements change during the next twelve months, management has the ability and commitment to make corresponding changes to our operating
10
expenses, capital expenditures, and investments as necessary. Until commercial production is achieved from our planned operations, we will continue to incur investing net cash outflows associated with, among other things, funding capital projects, development-stage technical studies, permitting activities associated with our projects, funding our expected commitments in Quebec and Ghana, maintaining and acquiring exploration properties and undertaking ongoing exploration activities. Our long-term success is dependent upon our ability to successfully raise additional capital or financing or enter into strategic partnership opportunities. Our long-term success is also dependent upon our ability to obtain certain permits and approvals, develop our planned portfolio of projects, earn revenues, and achieve profitability.
Our unaudited consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
Significant Accounting Policies
Revenue Recognition
We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. A performance obligation is deemed to be satisfied when control of the product is transferred to our customer, which is typically upon delivery to the shipping carrier. Where a contract contains more than one distinct performance obligation, the transaction price is allocated to each performance obligation based on the standalone selling price of each performance obligation, although these situations do not occur frequently and are generally not built into our contracts. Revenue is measured as the amount of consideration expected to be received in exchange for transferring the goods. Initial pricing is typically billed 5 days to 30 days after the departure of the shipment and paid between 15 days to 75 days. Final adjustments to prices may take longer to resolve. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. We warrant to our customers that our products conform to mutually agreed product specifications.
We have elected to account for shipping and handling costs for spodumene concentrate contracts as fulfillment activities and not as promised goods or services; therefore, these activities are not considered separate performance obligations. We have elected the practical expedient relating to significant financing components and as such will not consider the possibility of a contract having a significant financing component (which would effectively attribute a portion of the sales price to interest income) unless, if at contract inception, the expected payment terms (from time of delivery or other relevant criterion) are more than one year.
Our lithium products are sold to global and regional customers in the electric vehicle and electronics markets, among others. We currently work with end users in a number of markets to tailor our products to their specifications and will work with these end users as we add more products.
There have been no other changes to significant accounting policies described in Note 2—Summary of Significant Accounting Policies within Part II, Item 8 of our Annual Report for the year ended December 31, 2022.
Recently Issued and Adopted Accounting Pronouncements
We have considered the applicability and impact of all recently issued accounting pronouncements and have determined that they were either not applicable or were not expected to have a material impact on our unaudited consolidated financial statements.
2.REVENUE
We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. A performance obligation is deemed to be satisfied when control of the product is transferred to our customer, which is typically upon delivery to the shipping carrier. There currently are no contracts with multiple performance obligations and there have been no unsatisfied performance obligations. Revenue is measured as the amount of consideration expected to be received in exchange for transferring the goods. Initial pricing is typically billed 5 days to 30 days after the departure of the shipment and paid between 15 days to 75 days. Final adjustments to prices may take longer to resolve. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. We warrant to our customers that our products conform to mutually agreed product specifications.
In the three and nine months ended September 30, 2023, two customers accounted for 100% of total revenue. All of the sales related to these two customers originated in North America. We evaluate the collectability of our accounts receivable on an individual customer basis. We had no reserve for uncollectible accounts as of September 30, 2023.
11
There are no contract assets or contract liabilities as of September 30, 2023.
We are subject to provisional revenue adjustments associated with commodity price fluctuations for our spodumene concentrate sales. These adjustments are unknown until final settlement.
3.STOCK-BASED COMPENSATION
Stock Incentive Plans
The Incentive Plan authorizes the grant of stock options, stock appreciation rights, restricted stock units, and restricted stock, any of which may be performance-based. Our Leadership and Compensation Committee determines the exercise price for stock options and the base price of stock appreciation rights, which may not be less than the fair market value of our common stock on the date of grant. Generally, stock options or stock appreciation rights vest after three years of service and expire at the end of ten years. PRAs vest upon achievement of certain pre-established performance targets that are based on specified performance criteria over a performance period. As of September 30, 2023, 2,143,116 shares of common stock were available for issuance under our Incentive Plan.
We include the expense related to stock-based compensation in the same financial statement line item as cash compensation paid to the same employee. As of September 30, 2023, we had remaining unvested stock-based compensation expense of $10.9 million to be recognized through December 2025. Additionally, and if applicable, we capitalize personnel expenses attributable to the development of our mine and construction of our plants, including stock-based compensation expenses. We recognize share-based award forfeitures as they occur.
Stock-based compensation related to all stock-based incentive plans is presented in the following table:
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
(in thousands) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Components of stock-based compensation: | |||||||||||||||||||||||
Stock-based compensation | $ | 3,139 | $ | 1,358 | $ | 7,576 | $ | 3,715 | |||||||||||||||
Stock-based compensation forfeitures | — | (8) | (5) | (859) | |||||||||||||||||||
Stock-based compensation, net of forfeitures | $ | 3,139 | $ | 1,350 | $ | 7,571 | $ | 2,856 | |||||||||||||||
Presentation of stock-based compensation in the unaudited consolidated financial statements: | |||||||||||||||||||||||
Exploration and mine development costs | $ | 57 | $ | 131 | $ | 128 | $ | 133 | |||||||||||||||
Selling, general, and administrative expenses | 3,010 | 1,129 | 7,250 | 2,510 | |||||||||||||||||||
Stock-based compensation expense, net of forfeitures(1) | 3,067 | 1,260 | 7,378 | 2,643 | |||||||||||||||||||
Capitalized stock-based compensation(2) | 72 | 90 | 193 | 213 | |||||||||||||||||||
Stock-based compensation, net of forfeitures | $ | 3,139 | $ | 1,350 | $ | 7,571 | $ | 2,856 |
(1)For the three and nine months ended September 30, 2023 and 2022, we did not reflect tax impacts associated with stock-based compensation expense in our consolidated statements of operations because we had a full tax valuation allowance in impacted jurisdictions during these periods.
(2)Capitalized stock-based compensation relates to direct labor costs associated with Carolina Lithium and Tennessee Lithium and is included in “Property, plant and mine development, net” in our consolidated balance sheets.
12
A summary of activity related to our share-based awards is presented in the following table:
2023 | 2022 | ||||||||||||||||||||||||||||||||||
(in thousands) | Stock Option Awards | Restricted Stock Units | Performance Rights Awards | Stock Option Awards | Restricted Stock Units | Performance Rights Awards | |||||||||||||||||||||||||||||
Balance at January 1 | 265 | 36 | 44 | 273 | 51 | 30 | |||||||||||||||||||||||||||||
Granted | 42 | 40 | 42 | 136 | 17 | 29 | |||||||||||||||||||||||||||||
Exercised, surrendered or vested | — | (13) | — | (15) | (14) | — | |||||||||||||||||||||||||||||
Forfeited or expired | — | (1) | — | (20) | (17) | — | |||||||||||||||||||||||||||||
Balance at March 31 | 307 | 62 | 86 | 374 | 37 | 59 | |||||||||||||||||||||||||||||
Granted | 30 | 31 | 27 | 59 | 8 | 10 | |||||||||||||||||||||||||||||
Exercised, surrendered or vested | — | (12) | — | (38) | (9) | — | |||||||||||||||||||||||||||||
Balance at June 30 | 337 | 81 | 113 | 395 | 36 | 69 | |||||||||||||||||||||||||||||
Granted | — | — | — | — | 3 | 10 | |||||||||||||||||||||||||||||
Exercised, surrendered or vested | (2) | — | (22) | (37) | (1) | — | |||||||||||||||||||||||||||||
Forfeited or expired | — | — | — | — | (1) | — | |||||||||||||||||||||||||||||
Balance at September 30 | 335 | 81 | 91 | 358 | 37 | 79 |
Stock Option Awards
Stock options may be granted to employees, officers, non-employee directors and other service providers. For stock option awards, the fair value is estimated at the date of grant using the Black-Scholes valuation model and the expense is recognized over the option vesting period.
Restricted Stock Unit Awards
RSUs are granted to employees and non-employee directors and recognized as stock-based compensation expense over the vesting period, subject to the passage of time and continued service during the vesting period, based on the market price of our common stock on the grant date. In some instances, awards may vest concurrently with or following an employee’s termination.
Performance Rights Awards
As of September 30, 2023, there were 22,000 unvested Milestone PRAs and 69,000 unvested TSR PRAs. The awards become eligible to vest only if the goals are achieved and will vest only if the grantee remains employed by the Company through each applicable vesting date. Each performance right converts into one share of common stock upon vesting of the performance right.
We determine the fair value of Milestone PRAs based upon the market price of our common stock on the grant date. Milestone PRAs are subject to certain milestones related to construction, feasibility studies, and offtake agreements, which must be satisfied in order for PRAs to vest.
We estimate the fair value of the TSR PRAs at the grant date using a Monte Carlo simulation. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including price volatility of the underlying stock. A Monte Carlo simulation model was used to determine the grant date fair value by simulating a range of possible future stock prices for the Company and each member of the peer group over the performance periods. Compensation expense is recognized based upon the assumption of 100% achievement of the TSR goal and is reflected over the service period of the award. Compensation expense will not be reversed even if the threshold level of TSR is never achieved. The number of shares that may vest ranges from 0% to 200% of the target amount. The awards, which range from 1 year to 3 years, provide for a partial payout based on actual performance at the conclusion of the performance period.
Each performance right converts into one share of common stock upon vesting of performance right.
13
4.EARNINGS PER SHARE
We compute basic and diluted earnings per common share by dividing net earnings by the respective weighted average number of common shares outstanding for the periods presented. Our calculation of diluted earnings per common share also includes the dilutive effects for the assumed vesting of outstanding options, RSUs, and PRAs based on the treasury stock method. In computing diluted earnings per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options. Diluted earnings per share excludes all dilutive potential shares if their effect is anti-dilutive.
Basic and diluted net income (loss) per share is reflected in the following table:
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
(in thousands, except per share amounts) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Net income (loss) | $ | 22,891 | $ | 16,665 | $ | 3,613 | $ | (2,071) | |||||||||||||||
Weighted-average number of common shares used in calculating basic earnings per share | 19,203 | 17,966 | 18,974 | 17,343 | |||||||||||||||||||
Effect of potentially dilutive equity awards | 36 | 115 | 37 | — | |||||||||||||||||||
Weighted-average number of common shares used in calculating dilutive earnings per share | 19,239 | 18,081 | 19,011 | 17,343 | |||||||||||||||||||
Basic net income (loss) per weighted-average share | $ | 1.19 | $ | 0.93 | $ | 0.19 | $ | (0.12) | |||||||||||||||
Diluted net income (loss) per weighted-average share | $ | 1.19 | $ | 0.92 | $ | 0.19 | $ | (0.12) |
Potentially dilutive shares were not included in the calculation of diluted net loss per share because their effect would have been anti-dilutive in those periods. PRAs were not included as their performance obligations had not been met. The potentially dilutive and anti-dilutive shares not included in diluted net loss per share are presented in the following table:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
(in thousands) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Stock options | 294 | 223 | 71 | 358 | ||||||||||||||||||||||
RSUs | 3 | 3 | 10 | 37 | ||||||||||||||||||||||
PRAs | 94 | 79 | 88 | 79 | ||||||||||||||||||||||
Total potentially dilutive shares | 391 | 305 | 169 | 474 |
5.INCOME TAXES
We recorded income tax expense of $2.0 million on income before taxes of $24.9 million and a provision of $3.4 million on income before taxes of $20.1 million in the three months ended September 30, 2023 and 2022, respectively. We recorded income tax expense of $3.2 million on income before taxes of $6.8 million and a provision of $3.4 million on income before taxes of $1.4 million in the nine months ended September 30, 2023 and 2022, respectively. The effective tax rates were 8.1% and 17% in the three months ended September 30, 2023 and 2022, respectively, and 46.7% and 253.3% in the nine months ended September 30, 2023 and 2022, respectively.
The decrease in income tax expense for the three and nine months ended September 30, 2023 as compared to the three and nine months ended September 30, 2022 was primarily due to a decrease in the gain on dilution in Sayona Mining during the three and nine months ended September 30, 2023. The effective tax rate differs from the U.S. federal statutory rate due to the valuation allowance against our U.S. deferred tax assets and income in foreign jurisdictions taxed at different rates than the U.S. statutory tax rate.
We intend to continue maintaining a valuation allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of the allowance. However, given our anticipated future earnings, we believe that there is a reasonable possibility that within the next 12 months, sufficient positive evidence may become available to allow us to reach a conclusion that a material portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease in income tax expense for the period in which the release is recorded. The exact timing and amount of the valuation allowance release are subject to change based on the level of profitability that we are able to
14
achieve. We continually review the adequacy of our valuation allowance and intend to maintain a valuation allowance on our deferred tax assets where there is not sufficient evidence to support realizability.
6.PROPERTY, PLANT AND MINE DEVELOPMENT
Property, plant and mine development, net, is presented in the following table:
(in thousands) | September 30, 2023 | December 31, 2022 | |||||||||
Mining interests | $ | 78,623 | $ | 56,120 | |||||||
Mine development | 4,971 | 3,050 | |||||||||
Land | 720 | 720 | |||||||||
Leasehold improvements | 401 | 281 | |||||||||
Facilities and equipment | 915 | 675 | |||||||||
Construction in process | 31,051 | 10,780 | |||||||||
Property, plant and mine development | 116,681 | 71,626 | |||||||||
Accumulated depreciation | (259) | (85) | |||||||||
Property, plant and mine development, net | $ | 116,422 | $ | 71,541 |
Mining interests and mine development costs relate to Carolina Lithium. Our construction in process primarily relates to capitalized costs associated with Tennessee Lithium.
Depletion of mining interests and mine development assets does not commence until the assets are placed in service. As of September 30, 2023, we have not recorded depletion expense for any of our mining interests or mine development assets.
Depreciation expense is included in “Selling, general and administrative expenses” in our consolidated statements of operations as follows:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
(in thousands) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Depreciation expense | $ | 68 | $ | 21 | $ | 174 | $ | 32 |
7.EQUITY METHOD INVESTMENTS
We apply the equity method to investments when we have the ability to exercise significant influence over the operational decision-making authority and financial policies of the investee. We account for our existing investments in Atlantic Lithium, Sayona Mining, and Sayona Quebec, a subsidiary of Sayona Mining, as equity method investments.
We continue to evaluate operational developments and the impact of the anticipated expansion of the operations of our existing equity method investees. As discussed below, Atlantic Lithium’s completion of a technical study for Ewoyaa, along with the restart of NAL, were impactful to the consideration of how we most appropriately reflect our proportional share of income (loss) from our three existing equity method investments. Offtake agreements with our equity method investees are expected to initially supply spodumene concentrate, which may be resold into the market. Upon completion of construction of Tennessee Lithium, our equity method investees are expected to supply the majority of the spodumene concentrate required by Tennessee Lithium for conversion to lithium hydroxide.
Our share of the income (loss) from Atlantic Lithium, Sayona Mining, and Sayona Quebec is recorded on a one-quarter lag in “Income (loss) from equity method investments” within “Income (loss) from operations” in our consolidated statements of operations.
Below is a summary of our equity method investments as of September 30, 2023.
15
Sayona Mining
We own an equity interest of approximately 12% in Sayona Mining, an Australian company publicly listed on the ASX, and have formed a strategic partnership with Sayona Mining to explore, evaluate, develop, mine, and produce spodumene concentrate in Quebec, Canada.
During the nine months ended September 30, 2023 and 2022, we reported the effects of Sayona Mining raising additional capital through share issuances of its common stock. We did not participate in these share issuances, which were issued at a valuation greater than the carrying value of our ownership interest. As a result, our ownership interest in Sayona Mining was diluted and declined. We recognized a noncash gain of $8.0 million and $29.4 million in the three months ended September 30, 2023 and 2022, respectively, and $15.2 million and $29.4 million in the nine months ended September 30, 2023, and 2022, respectively, related to the dilution of our ownership interest. We recorded the gain within “Gain on dilution of equity method investments” in our consolidated statements of operations.
Sayona Quebec
We own an equity interest of 25% in Sayona Quebec for the purpose of furthering our investment and strategic partnership in Quebec, Canada. The remaining 75% equity interest is held by Sayona Mining. Sayona Quebec holds a 100% interest in NAL, which consists of a surface mine and a concentrator plant, as well as the Authier Lithium Project and the Tansim Lithium Project.
We hold a life-of-mine offtake agreement with Sayona Quebec for the greater of 113,000 metric tons or 50% of spodumene concentrate production per year. Our purchases of spodumene concentrate from Sayona Quebec are subject to market pricing with a price floor of $500 per metric ton and a price ceiling of $900 per metric ton for 6.0% spodumene concentrate on an FOB North Carolina basis.
In addition to lithium mining and concentrate production, NAL owns a partially completed lithium carbonate plant, which was developed by a prior operator of NAL. Sayona Quebec completed a preliminary technical study for the completion and restart of the NAL carbonate plant during the quarter ended June 30, 2023. If we decide to construct and operate a lithium conversion plant with Sayona Mining through our joint venture, Sayona Quebec, spodumene concentrate produced from NAL would be preferentially delivered to that conversion plant upon commencement of conversion operations. Any remaining spodumene concentrate not delivered the conversion plant would first be sold to us up to our offtake right and then to third parties. Any decision to construct jointly-owned lithium conversion capacity must be agreed upon by both parties.
Atlantic Lithium
We own an equity interest of approximately 9% in Atlantic Lithium, an Australian company publicly listed on the Alternative Investment Market of the London Stock Exchange and the ASX. We have a strategic partnership with Atlantic Lithium to explore, evaluate, mine, develop, and ultimately produce spodumene concentrate in Ghana. We have the right to acquire up to a 50% equity interest in Atlantic Lithium Ghana, a subsidiary of Atlantic Lithium that owns Ewoyaa, through current and future phased investments.
We have a long-term offtake agreement whereby Atlantic Lithium will sell 50% of spodumene concentrate produced in Ghana for the life of the mine to Piedmont Lithium at market prices. See Note 8—Other Assets and Liabilities.
16
The following tables summarize the carrying amounts, including changes therein, of our equity method investments:
Three Months Ended September 30, 2023 | |||||||||||||||||||||||
(in thousands) | Sayona Mining | Sayona Quebec | Atlantic Lithium | Total | |||||||||||||||||||
Balance at June 30, 2023 | $ | 47,283 | $ | 66,546 | $ | 10,211 | $ | 124,040 | |||||||||||||||
Additional investments | 450 | — | — | 450 | |||||||||||||||||||
Gain on dilution of equity method investments(1) | 7,894 | — | 64 | 7,958 | |||||||||||||||||||
Income (loss) from equity method investments(2) | 1,076 | 3,552 | (776) | 3,852 | |||||||||||||||||||
Foreign currency translation adjustment of equity method investments | (1,394) | (1,618) | (244) | (3,256) | |||||||||||||||||||
Balance at September 30, 2023 | $ | 55,309 | $ | 68,480 | $ | 9,255 | $ | 133,044 |
(1)Gain on dilution of equity method investments relates to issuances of additional shares of Sayona Mining and Atlantic Lithium, which reduced our ownership interest in both Sayona Mining and Atlantic Lithium.
(2)Certain immaterial, out-of-period amounts, related to our proportionate share of the results of Sayona Mining and Sayona Quebec have been included in our current period results.
Nine Months Ended September 30, 2023 | |||||||||||||||||||||||
(in thousands) | Sayona Mining | Sayona Quebec | Atlantic Lithium | Total | |||||||||||||||||||
Balance at December 31, 2022 | $ | 44,620 | $ | 39,763 | $ | 11,265 | $ | 95,648 | |||||||||||||||
Additional investments | 550 | 28,076 | 41 | 28,667 | |||||||||||||||||||
Gain on dilution of equity method investments(1) | 15,144 | — | 64 | 15,208 | |||||||||||||||||||
Income (loss) from equity method investments(2) | (978) | 948 | (1,535) | (1,565) | |||||||||||||||||||
Foreign currency translation adjustment of equity method investments | (4,027) | (307) | (580) | (4,914) | |||||||||||||||||||
Balance at September 30, 2023 | $ | 55,309 | $ | 68,480 | $ | 9,255 | $ | 133,044 |
(1)Gain on dilution of equity method investments relates to issuances of additional shares of Sayona Mining and Atlantic Lithium, which reduced our ownership interest in both Sayona Mining and Atlantic Lithium.
(2)Certain immaterial, out-of-period amounts, related to our proportionate share of the results of Sayona Mining and Sayona Quebec have been included in our current period results.
Three Months Ended September 30, 2022 | |||||||||||||||||||||||
(in thousands) | Sayona Mining | Sayona Quebec | Atlantic Lithium | Total | |||||||||||||||||||
Balance at June 30, 2022 | $ | 17,118 | $ | 33,047 | $ | 14,069 | $ | 64,234 | |||||||||||||||
Additional investments | — | 4,032 | — | 4,032 | |||||||||||||||||||
Gain (loss) on dilution of equity method investments (1) | 29,402 | — | (35) | 29,367 | |||||||||||||||||||
Loss from equity method investments | (228) | (454) | (1,321) | (2,003) | |||||||||||||||||||
Foreign currency translation adjustment of equity method investments | 1,336 | — | (133) | 1,203 | |||||||||||||||||||
Balance at September 30, 2022 | $ | 47,628 | $ | 36,625 | $ | 12,580 | $ | 96,833 |
__________________________
(1)Gain (loss) on dilution of equity method investments relates to: (i) issuances of additional shares of Sayona, which reduced our ownership interest in Sayona, and (ii) the exercise of certain Atlantic Lithium stock options and share grants which resulted in a reduction of our ownership in Atlantic Lithium.
17
Nine Months Ended September 30, 2022 | |||||||||||||||||||||||
(in thousands) | Sayona Mining | Sayona Quebec | Atlantic Lithium | Total | |||||||||||||||||||
Balance at December 31, 2021 | $ | 18,256 | $ | 25,216 | $ | 15,401 | $ | 58,873 | |||||||||||||||
Additional investments | 1,076 | 13,011 | — | 14,087 | |||||||||||||||||||
Gain (loss) on dilution of equity method investments (1) | 29,402 | — | (35) | 29,367 | |||||||||||||||||||
Loss from equity method investments | (2,507) | (1,647) | (2,393) | (6,547) | |||||||||||||||||||
Foreign currency translation adjustment of equity method investments | 1,401 | 45 | (393) | 1,053 | |||||||||||||||||||
Balance at September 30, 2022 | $ | 47,628 | $ | 36,625 | $ | 12,580 | $ | 96,833 |
__________________________
(1)Gain (loss) on dilution of equity method investments relates to: (i) issuances of additional shares of Sayona, which reduced our ownership interest in Sayona, and (ii) the exercise of certain Atlantic Lithium stock options and share grants which resulted in a reduction of our ownership in Atlantic Lithium.
The following table summarizes the fair value of equity method investments where market values from publicly traded entities are readily available:
As of September 30, 2023 | |||||||||||||||||
(in thousands) | Sayona Mining | Sayona Quebec | Atlantic Lithium | ||||||||||||||
Fair value | $ | 74,784 | Not publicly traded | $ | 18,404 |
8.OTHER ASSETS AND LIABILITIES
Other current assets consisted of the following:
(in thousands) | September 30, 2023 | December 31, 2022 | |||||||||
Investments in equity securities | $ | 458 | $ | 484 | |||||||
Prepaid and other current assets | 3,916 | 2,128 | |||||||||
Total other current assets | $ | 4,374 | $ | 2,612 |
As of September 30, 2023, our investments in equity securities consisted of common shares in Ricca, which we acquired as part of a spin-out of Ricca from Atlantic Lithium. Ricca is a private company focused on gold exploration in Africa.
Other non-current assets consisted of the following:
(in thousands) | September 30, 2023 | December 31, 2022 | |||||||||
Advances to affiliates | $ | 24,031 | $ | 17,316 | |||||||
Other non-current assets | 256 | 264 | |||||||||
Operating lease right-of-use assets | 1,447 | 1,293 | |||||||||
Total other non-current assets | $ | 25,734 | $ | 18,873 |
Advances to affiliates relate to staged investments for future planned lithium projects. We have a strategic partnership with Atlantic Lithium that includes Atlantic Lithium Ghana. Under our partnership, we entered into a project agreement to acquire a 50% equity interest in Atlantic Lithium Ghana in two phases, each requiring us to make future staged investments in Ewoyaa over a period of time.
We recently completed phase 1, which allows us to acquire a 22.5% equity interest in Atlantic Lithium Ghana by funding Ewoyaa’s exploration and DFS costs and notifying Atlantic Lithium of our intention to proceed with additional funding required under phase 2. We completed funding of exploration and DFS costs, and Atlantic Lithium issued their DFS in June 2023. In August, we supplied Atlantic Lithium with notification of our intent to proceed with additional funding. Our future equity interest ownership under phase 1 remains subject to government approvals required under Ghana’s Mineral and Mining Act. Phase 2 allows us to acquire an additional 27.5% equity interest in Atlantic Lithium Ghana upon completion of funding $70 million for capital costs associated with the development of Ewoyaa. Any cost savings or cost overruns from the initial commitment will be shared equally between Piedmont Lithium and Atlantic Lithium. Upon completion of phases 1 and 2, we expect to have a total equity interest of 50% in Atlantic Lithium Ghana. Atlantic Lithium Ghana, in turn, will hold an 81% interest in the Ewoyaa Project net of the interests which will be held by the
18
Ghanaian government, resulting in an effective ownership interest of 40.5% in Ewoyaa, by Piedmont. Funding costs are included in “Other non-current assets” in our consolidated balance sheets as an advance on our future phased investments in Atlantic Lithium Ghana.
Our maximum exposure to a loss as a result of our involvement in Ewoyaa is limited to the total funding paid by Piedmont Lithium to Atlantic Lithium. As of September 30, 2023, we did not own an equity interest in Atlantic Lithium Ghana. We have made advanced payments to Atlantic Lithium for Ewoyaa totaling $2.1 million and $2.7 million during the three months ended September 30, 2023 and 2022, respectively, and $6.9 million, and $9.8 million during the nine months ended September 30, 2023 and 2022, respectively.
Other current liabilities consisted of the following:
(in thousands) | September 30, 2023 | December 31, 2022 | |||||||||
Operating lease liabilities | $ | 301 | $ | 124 | |||||||
Accrued provisional revenue adjustment | 7,751 | — | |||||||||
Total other current liabilities | $ | 8,052 | $ | 124 |
We received a $31.6 million partial prepayment on our first sale of spodumene concentrate under a provisional pricing arrangement. We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. Differences between payments received and the final estimated sales price, which results in a liability, are recorded as accrued provisional revenue adjustments.
9.EQUITY
We are authorized to issue up to 100,000,000 shares of common stock, par value $0.0001 per share, and 10,000,000 shares of preferred stock, par value $0.0001 per share. We have no outstanding shares of preferred stock.
In February 2023, we received $75 million from LG Chem in exchange for 1,096,535 common shares in Piedmont Lithium at an approximate price of $68.40 per share and in conjunction with a multi-year spodumene concentrate offtake agreement. Share issuance costs associated with the subscription totaled $3.9 million and were accounted for as a reduction in the proceeds from share issuances in the consolidated balance sheets.
In March 2022, we issued 2,012,500 shares under our $500 million automatic shelf registration with an issue price of $65.00 per share to raise gross proceeds of $130.8 million. Share issuance costs associated with the U.S. public offering totaled $8.8 million and were accounted for as a reduction in the proceeds from share issuance in the consolidated balance sheets.
As of September 30, 2023, we had $369.2 million remaining under our shelf registration statement, which expires on September 24, 2024.
10.SEGMENT REPORTING
We report our segment information in the same way management internally organizes the business in assessing performance and making decisions regarding allocation of resources in accordance with ASC Topic 280, “Segment Reporting.” We have a single reportable operating segment that operates as a single business platform. In reaching this conclusion, management considered the definition of the CODM, how the business is defined by the CODM, the nature of the information provided to the CODM, how the CODM uses such information to make operating decisions, and how resources and performance are assessed. The results of operations provided to and analyzed by the CODM are at the consolidated level, and accordingly, key resource decisions and assessment of performance are performed at the consolidated level. We have a single, common management team and our cash flows are reported and reviewed at the consolidated level only with no distinct cash flows at an individual business level.
11.FAIR VALUE OF FINANCIAL INSTRUMENTS
Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.
We follow FASB ASC Topic 820, “Fair Value Measurement and Disclosure,” which establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy categorizes assets and liabilities measured at fair value into one of
19
three different levels depending on the observability of the inputs employed in the measurement. The three levels are defined as follows:
Level 1:Quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2:Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived from observable market data by correlation or other means.
Level 3:Inputs for the asset or liability that are not based on observable market data (unobservable inputs).
The level within which the financial asset or liability is classified is determined based on the lowest level of significant input to the fair value measurement.
Measurement of Fair Value
Our financial instruments consist primarily of cash and cash equivalents, investments in equity securities, trade and other payables, and long-term debt as follows:
•Other financial instruments—The carrying amounts of cash and cash equivalents, and trade and other payables approximate fair value due to their short-term nature.
•Investments in equity securities—As of September 30, 2023 and December 31, 2022, we had $0.5 million and $0.5 million, respectively, of investments in equity securities which are recorded at fair value based on Level 3 inputs. See Note 8—Other Assets and Liabilities.
•Long-term debt—Principal debt outstanding associated with seller financed loans was $0.2 million and $0.6 million as of September 30, 2023 and December 31, 2022, respectively. The carrying value of our long-term debt approximates its estimated fair value.
Level 3 activity was not material for all periods presented.
12.COMMITMENTS AND CONTINGENCIES
Legal Proceedings
We are involved from time to time in various claims, proceedings, and litigation. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated.
On July 5, 2022, Brad Thomascik, a purported shareholder of the Company’s equity securities, filed a shareholder derivative lawsuit in the U.S. District Court for the Eastern District of New York. On behalf of the Company, the lawsuit purports to bring claims against certain of the Company’s officers and directors. The complaint alleges that the defendants breached their fiduciary duties in connection with the Company’s statements regarding the timing and status of government permits for Carolina Lithium in North Carolina at various times between March 16, 2018 and July 19, 2021. No litigation demand was made to the Company in connection with this action. The lawsuit focuses on the same public statements as the shareholder derivative suit described above. In September 2022, the parties agreed to a stipulation to stay the proceeding pending resolution of the motion to dismiss in the securities law matters described in the second paragraph of this section, and the Court ordered the case stayed in October 2022. We intend to vigorously defend against these claims. Although there can be no assurance as to the outcome, we do not believe these claims have merit. The potential monetary relief, if any, is not probable and cannot be estimated at this time; accordingly, we have not recorded a liability for this matter.
On October 14, 2021, Vincent Varbaro, a purported holder of Piedmont Australia’s American Depositary Shares and the Company’s equity securities, filed a shareholder derivative suit in the U.S. District Court for the Eastern District of New York, purporting to bring claims on behalf of the Company against certain of the Company’s officers and directors. The complaint alleges that the defendants breached their fiduciary duties in connection with the Company’s statements regarding the timing and status of government permits for Carolina Lithium in North Carolina, at various times between March 16, 2018 and July 19, 2021. No litigation demand was made to the Company in connection with this action. In December 2021, the parties agreed to a stipulation to stay the proceeding pending resolution of the motion to dismiss in the securities law matters described in the immediately preceding paragraph, and the Court ordered the case stayed. We intend to vigorously defend against these claims. Although there can be no assurance as to the outcome,
20
we do not believe these claims have merit. The potential monetary relief, if any, is not probable and cannot be estimated at this time; accordingly, we have not recorded a liability for this matter.
On September 8, 2023, the parties in the Thomascik and Varbaro cases stipulated to consolidate the two actions. That stipulation has not yet been acted on by the court.
In July 2021, a lawsuit was filed against us in the U.S. District Court for the Eastern District of New York on behalf of a class of putative plaintiffs claiming violations of the Exchange Act. The complaint alleged, among other things, that we made false and/or misleading statements and/or failed to make disclosure relating to proper and necessary permits. In February 2022, the Court appointed a lead plaintiff in this action, and the lead plaintiff filed an amended complaint in April 2022. On July 18, 2022, we moved to dismiss the amended complaint. On September 1, 2022, the lead plaintiff filed his Memorandum of Law in Opposition to our Motion to Dismiss. On October 7, 2022, we filed our Reply Memorandum in support of our Motion to Dismiss. The Court has yet to rule on our Motion to Dismiss. We intend to vigorously defend against these claims should the amended complaint survive. Although there can be no assurance as to the outcome, we do not believe these claims have merit. The potential monetary relief, if any, is not probable and cannot be estimated at this time, accordingly, we have not recorded a liability for this matter.
Other Commitments and Contingencies
In May 2023, we entered into a community development agreement with the City of Cherryville, North Carolina, whereby we committed to fund $11.0 million as follows: (i) $1.0 million to support certain parks and recreation projects and the reestablishment of a department of recreation, of which $0.5 million was paid in July 2023 and $0.5 million was paid in October 2023, and (ii) $10.0 million paid in annual installments of $0.5 million over a 20-year period commencing upon the first shipment of lithium hydroxide from Carolina Lithium. As part of the agreement, the City of Cherryville relinquished extraterritorial zoning jurisdiction over certain real property owned by Piedmont Lithium to Gaston County, North Carolina.
13.SUBSEQUENT EVENTS
In October 2023, we paid $1.5 million for a 19.9% equity interest in Vinland Lithium, a new entity established with Sokoman Minerals (40.05% owners) and Benton Resources (40.05% owners). Through a staged investment agreement, we can earn up to 62.5% equity interest in Killick Lithium, a wholly-owned subsidiary of Vinland Lithium Inc. that currently holds a 100% interest in the Killick Lithium project, a large prospective lithium project in Newfoundland, Canada.
21
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in our Quarterly Report. References in this Form 10-Q to our Form 10-K refer to our Form 10-K, filed on March 1, 2023, as amended by our Form 10-K/A on April 24, 2023. The following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in our Quarterly Report and those in the sections of our Annual Report for the year ended December 31, 2022 entitled “Risk Factors,” “Cautionary Note Regarding Forward-Looking Statements,” and “Cautionary Note Regarding Disclosure of Mineral Properties.”
This management’s discussion and analysis is a supplement to our financial statements, including notes, referenced elsewhere in our Quarterly Report and is provided to enhance your understanding of our operations and financial condition. This discussion is presented in millions, and due to rounding, may not sum or calculate precisely to the totals and percentages provided in the tables.
Executive Overview & Strategy
We are a U.S. development-stage company with the aim of becoming one of the leading producers of lithium hydroxide in North America. As the world, the American government, and industries mobilize to support global decarbonization through the electrification of transportation, we are poised to become a critical contributor to the U.S. electric vehicle and battery manufacturing supply chains.
Since 2021, electric vehicle and battery companies have announced significant commitments to build new or expanded manufacturing operations across the U.S., which is expected to exponentially and rapidly drive the domestic demand for lithium over the next decade, far beyond current or projected capacity. Piedmont Lithium, as a U.S. based company, is well positioned to benefit from federal policies and funding established to facilitate the expedited development of a robust domestic supply chain and clean energy economy, while strengthening national and global energy security. A challenge faced by the industry is that while manufacturing facilities for electric vehicles, batteries, and related components are typically constructed in two to three years, the development of lithium resources from exploration to production requires a much longer time frame. We believe that the prolonged time frame for resource development is the greatest risk to the emerging electrification industry, but also represents opportunities for lithium producers.
To support growing U.S. lithium demand, we have spent the past seven years developing a portfolio of four projects: wholly-owned Tennessee Lithium and Carolina Lithium, strategic investments in Quebec, Canada, with Sayona Mining and Sayona Quebec, and in Ghana with Atlantic Lithium. Our joint venture with Sayona Mining, Sayona Quebec, began supplying spodumene concentrate to the market in the third quarter of 2023. Our future investment in Atlantic Lithium Ghana is expected to produce spodumene concentrate in 2025. We anticipate spodumene concentrate from Ghana will serve as the primary feedstock for Tennessee Lithium. Tennessee Lithium is being designed to produce 30,000 metric tons of lithium hydroxide annually. Carolina Lithium is being developed as a fully integrated spodumene concentrate-to-lithium hydroxide project designed to produce 30,000 metric tons of lithium hydroxide annually.
We currently plan to produce an estimated 60,000 metric tons per year of domestic lithium hydroxide, which would be significantly accretive to today’s total estimated U.S. annual production capacity of just 20,000 metric tons per year. Our lithium hydroxide capacity and revenue generation are expected to be supported by production of, or offtake rights to, approximately 525,000 dmt of spodumene concentrate annually.
Our projects and strategic investments are being developed on a measured timeline to provide the potential for near-term cash flow and long-term value maximization as we explore opportunities to grow our hard rock lithium base through other investments. The development timelines are subject to permitting, regulatory approvals, funding, successful project execution, and market dynamics. We also continue to evaluate opportunities to further expand our resource base and production capacity.
As we continue to advance our goal of becoming one of the leading manufacturers of lithium products in North America, we expect to capitalize on our competitive strengths, including our life-of-mine offtake agreement with Sayona Quebec, scale and diversification of lithium resources, advantageous locations of projects and assets, access to a variety of funding options, opportunities to leverage our greenfield projects, and a highly experienced management team. Advancements that have been made toward this effort are highlighted below.
22
Piedmont Lithium
We continue to engage in activities to strengthen our financial position and business strategy, including support for the development and expansion of our portfolio of projects, strategic investments, and corporate operations.
In October 2023, we paid $1.5 million for a 19.9% equity interest in Vinland Lithium, which is a Canadian-based entity jointly owned with Sokoman Minerals and Benton Resources. Vinland Lithium currently owns the Killick Lithium Project, a large exploration property prospective for lithium located in southern Newfoundland, Canada. We have entered into an earn-in agreement with Vinland Lithium to acquire up to a 62.5% equity interest in Killick Lithium through staged-investments. As part of our investment, we entered into a marketing agreement with Killick Lithium for 100% marketing rights and right of first refusal to purchase 100% of all lithium products produced by Killick Lithium on a life-of-mine basis at competitive commercial rates.
Lithium Projects
Quebec
We own equity interests of approximately 12% and 25% in Sayona Mining and Sayona Quebec, respectively. Sayona Mining owns the remaining 75% equity interest in Sayona Quebec. Sayona Quebec owns a portfolio of projects, which includes NAL, the Authier Lithium Project, and the Tansim Lithium Project. We hold a life-of-mine offtake agreement with Sayona Quebec for the greater of 113,000 metric tons or 50% of spodumene concentrate production per year. Our purchases of spodumene concentrate are subject to a price floor of $500 per metric ton and a price ceiling of $900 per metric ton for 6.0% Li2O spodumene concentrate on an FOB North Carolina basis.
Recent highlights include:
•During the three months ended September 30, 2023, NAL produced 31,486 dmt of spodumene concentrate and shipped 48,211 dmt of spodumene concentrate, of which 29,011 dmt spodumene concentrate were sold to Piedmont.
•In October 2023, Sayona Mining provided a forecast for the one-year period July 1, 2023 through June 30, 2024 projecting production of 140,000 to 160,000 dmt of spodumene concentrate and shipments of 160,000 to 180,000 dmt of spodumene concentrate at NAL.
•In November 2023, Sayona announced drill results from the 2023 drill campaign at NAL including significant intercepts of spodumene bearing pegmatites in a Northwest direction from the existing pit shell. Drilling encountered thick, high-grade pegmatites. Additional assay results are pending.
Ghana
We own an equity interest of approximately 9% in Atlantic Lithium, and we have a right to acquire 50% equity interest in Atlantic Lithium Ghana, which includes Atlantic’s flagship Ewoyaa Lithium Project located approximately 70 miles from the Port of Takoradi in Ghana, West Africa. We hold an offtake agreement with Atlantic Lithium for 50% of annual production of spodumene concentrate at market prices on a life-of-mine basis from Ewoyaa. As part of our strategy, we expect to transport our 50% offtake of spodumene concentrate from Ewoyaa to the U.S. to serve as the primary feedstock for lithium hydroxide conversion at Tennessee Lithium.
Recent highlights include:
•In October 2023, Ghana’s Ministry of Lands and Natural Resources granted a mining lease for Ewoyaa, subject to ratification by the Ghanaian Parliament. The mining lease includes a 13% free-carried interest in Ewoyaa for the Government of Ghana, and a 10% royalty. The mining lease remains subject to parliamentary ratification.
•In September 2023, the MIIF entered into a non-binding agreement with Atlantic Lithium to invest $27.9 million to acquire a 6% equity interest in Ewoyaa, with the investment earmarked for Ewoyaa’s project development costs, and to fund 6% of all future exploration and development costs within Atlantic Lithium’s Ghanaian portfolio. MIIF’s investment is expected to equally reduce Piedmont and Atlantic Lithium’s funding requirements for Ewoyaa. If executed, Piedmont and Atlantic Lithium would each own a 40.5% equity interest in Ewoyaa, inclusive of the government’s free-carried interest. Piedmont would continue to maintain a 50% life-of-mine offtake right to future spodumene concentrate production from Atlantic Lithium Ghana under these agreements.
23
•In August 2023, we exercised our option to acquire a 22.5% equity interest in Atlantic Lithium Ghana, subject to government approvals, as part of an earn-in agreement to acquire a 50% equity interest in Atlantic Lithium Ghana, excluding the MIIF investment and the government’s free-carried interest. Additionally, we have committed to fund the first $70.0 million of capital expenditures for the development of Ewoyaa, which will allow us to earn the remaining 27.5% equity interest in Atlantic Lithium Ghana. Additional capital costs for development will be shared equally with Atlantic Lithium.
•Atlantic Lithium expects permitting and approvals for Ewoyaa to be finalized in the second half of 2024, with first production from the modular dense medium separation plant expected in the second half of 2025. Full commercial production is targeted for 2026, subject to approval of environmental studies, parliamentary ratification, and other statutory requirements.
Tennessee Lithium
Tennessee Lithium is being designed as a world-class lithium hydroxide facility in America’s emerging “Battery Belt” and is expected to add 30,000 metric tons per year of lithium hydroxide production capacity to the U.S. supply chain. We expect the plant to be one of the most sustainable lithium hydroxide operations in the world and will utilize the Metso:Outotec alkaline pressure leaching technology. Use of this technology is expected to reduce solid waste, create fewer emissions, and improve capital and operating costs relative to incumbent technologies.
Recent highlights include:
•In October 2023, we purchased a tailings storage facility adjacent to the proposed Tennessee Lithium plant site for the placement of inert tailings produced as part of the innovative alkaline pressure leach process. In addition, we agreed to acquire a large industrial complex in close proximity to the Tennessee Lithium plant site. These two acquisitions should result in significant net economic benefits to the project.
•During the third quarter 2023, we engaged advisors to support our funding strategy for the construction of Tennessee Lithium. In consultation with the DOE, we have decided to pursue an ATVM loan under the DOE’s Loan Programs Office, rather than complete the previously announced $141.7 million grant under the Bipartisan Infrastructure Law. We expect that the ATVM loan, if awarded, would cover a significantly larger share of the capital required for the project, strengthening the opportunity for strategic parties to partner with us on the project.
•During the third quarter 2023, we exercised our option to acquire the proposed site of the Tennessee Lithium project and are working with the local authorities towards property closing.
•In July 2023, we received our Conditional Major Non-Title V Construction and Operating Air Permit for Tennessee Lithium from TDEC. With the receipt of the Air Permit for the planned 30,000 metric ton per year lithium hydroxide manufacturing plant, we now hold all the material permits required to begin construction at Tennessee Lithium.
Carolina Lithium
Carolina Lithium is located in the historic Carolina Tin-Spodumene Belt and is being designed as a fully integrated project with mining, spodumene concentrate production, and lithium hydroxide manufacturing on a single site in Gaston County, North Carolina. At full production, Carolina Lithium is expected to produce 30,000 metric tons per year of lithium hydroxide. We are currently engaged in permitting activities with state and local regulatory and governing bodies. Our goal is to obtain the necessary material permits in 2024. We expect to proceed with rezoning following receipt of a state mining permit. Construction will commence upon receipt of required permits, rezoning, local approvals, and project financing activities.
We submitted our mining permit application to the NCDEQ and DEMLR in August 2021. In May 2023, DEMLR issued their third Additional Information Request, seeking further clarification on our plans to address environmental monitoring and mitigation. In September 2023, we submitted a partial draft response. We may, based on feedback to our partial draft response, request an extension of time to respond to the Additional Information Request.
Critical Accounting Polices and Estimates
Our management’s discussion and analysis of our financial condition and results of operations is based on our unaudited consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable
24
under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
See Significant Accounting Policies section in Note 1—Description of Company for any changes in the significant accounting policies followed by us during the nine months ended September 30, 2023, from those disclosed in our Annual Report for the year ended December 31, 2022.
COVID-19 Response
To protect the health and safety of our employees, contractors, visitors, and communities, we implemented a comprehensive plan in response to the COVID-19 pandemic. Our plan included policies and protocols governing issues such as close contact exposure and contraction of COVID-19 and other communicable diseases, providing employees with additional personal protective equipment and allowing our employees to work remotely. We have provided paid time off for employees impacted by COVID-19, reimbursed employees for costs associated with COVID-19 testing, provided time for employees to get vaccinated, and encouraged flexible work schedules to accommodate personal and family needs. Currently, the rate of COVID-19 outbreaks in the U.S. appears to be significantly reduced, but the possibility of new strains emerging continues to pose a risk. While our business has not been materially impacted, the global economy and our markets have been, and may continue to be, materially and adversely effected by COVID-19. If the impact of COVID-19 is not effectively and timely controlled on a sustained basis going forward, our business operations and financial condition may be materially and adversely effected by factors that we cannot foresee. Any of these factors and other factors beyond our control could have an adverse effect on the overall business environment, cause uncertainties in the regions where we conduct business, cause our business to suffer in ways that we cannot predict and materially and adversely impact our business, financial condition, and results of operations.
Components of our Results of Operations
Revenue
We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. A performance obligation is deemed to be satisfied when control of the product is transferred to our customer, which is typically upon delivery to the shipping carrier. Where a contract contains more than one distinct performance obligation, the transaction price is allocated to each performance obligation based on the standalone selling price of each performance obligation, although these situations do not occur frequently and are generally not built into our contracts. Revenue is measured as the amount of consideration expected to be received in exchange for transferring the goods. Initial pricing is typically billed 5 days to 30 days after the departure of the shipment and paid between 15 days to 75 days. Final adjustments to prices may take longer to resolve. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. We warrant to our customers that our products conform to mutually agreed product specifications.
Exploration and Mine Development Costs
We incur costs in resource exploration, evaluation, and development during the different phases of our resource development projects. Exploration costs incurred before the declaration of proven and probable mineral reserves, which primarily include exploration, drilling, engineering, metallurgical testwork, site-specific reclamation, and compensation for employees associated with exploration activities, are expensed as incurred. We have also expensed as incurred engineering costs attributable to the evaluation of land for our future concentrator and chemical plants, feasibility studies and other project expenses that do not qualify for capitalization. After proven and probable mineral reserves are declared, exploration and mine development costs necessary to bring the property to commercial capacity or increase the capacity or useful life will be capitalized.
Selling, General and Administrative Expenses
Selling, general and administrative expenses relate to overhead costs, such as employee compensation and benefits for corporate management and office staff including accounting, legal, human resources, and other support personnel, professional service fees, insurance, and costs associated with maintaining our corporate headquarters. Included in employee compensation costs are cash and stock-based compensation expenses.
Income (Loss) From Equity Method Investments
Income (loss) from equity method investments reflects our proportionate share of the net income (loss) resulting from our investments in Sayona Mining, Sayona Quebec, and Atlantic Lithium. These investments are recorded under the equity method and adjusted each
25
period, on a one-quarter lag, for our share of each investee’s income (loss). Our equity method investments are an integral and integrated part of our ongoing operations. We have determined this justifies a more meaningful and transparent presentation of our proportional share of income in our equity method investments as a component of our income (loss) from operations.
Other Income
Other income consists of interest income, interest expense, foreign currency exchange loss, and gain on dilution of equity method investments. Interest income consists of interest earned on our cash and cash equivalents. Interest expense consists of interest incurred on long-term debt related to noncash acquisitions of mining interests financed by sellers for Carolina Lithium as well as interest incurred for lease liabilities. Foreign currency exchange loss relates to our foreign bank accounts denominated in Canadian dollars and Australian dollars and marketable securities denominated in Australian dollars. Gain on dilution of equity method investments relates to our reduction in ownership of Sayona Mining and Atlantic Lithium due to their issuance of additional shares through public offerings and employee stock compensation grants.
Results of Operations
Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022
Three Months Ended September 30, | |||||||||||||||||||||||
(in thousands) | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||
Revenue | $ | 47,127 | $ | — | $ | 47,127 | * | ||||||||||||||||
Cost of sales | 23,363 | — | 23,363 | * | |||||||||||||||||||
Gross profit | 23,764 | — | 23,764 | * | |||||||||||||||||||
Gross profit margin | 50.4 | % | — | % | |||||||||||||||||||
Exploration and mine development costs | 471 | 434 | 37 | 8.5% | |||||||||||||||||||
Selling, general, and administrative expenses | 11,185 | 7,160 | 4,025 | 56.2% | |||||||||||||||||||
Total operating expenses | 11,656 | 7,594 | 4,062 | 53.5% | |||||||||||||||||||
Income (loss) from equity method investments | 3,852 | (2,003) | 5,855 | 292.3% | |||||||||||||||||||
Income (loss) from operations | 15,960 | (9,597) | 25,557 | 266.3% | |||||||||||||||||||
Other income | 8,959 | 29,684 | (20,725) | (72.9%) | |||||||||||||||||||
Income tax expense | 2,028 | 3,422 | (1,394) | (40.7%) | |||||||||||||||||||
Net income | $ | 22,891 | $ | 16,665 | $ | 6,226 | 37.4% |
* Not meaningful.
Revenue
Revenue was $47.1 million in the three months ended September 30, 2023 from the sale of 29,011 dmt of spodumene concentrate from our purchase offtake agreement with NAL. We had no sales in the three months ended September 30, 2022. The realized price per dmt was $1,624 for the three months ended September 30, 2023. Realized price is the average estimated price, net of certain distribution and other fees, for approximately 5.3% Li2O grade, which includes referenced pricing data up to September 30, 2023, and is subject to final adjustment. The final adjusted price may be higher or lower than the average estimated realized price based future market price movements. We have estimated the final sales pricing based on expected market conditions and known quality measurements. Any adjustments to the sales price will be reflected in subsequent periods.
Gross Profit and Gross Profit Margin
Gross profit was $23.8 million and gross profit margin was 50.4% in the three months ended September 30, 2023. Gross profit and gross profit margin was driven by our preferential offtake supply agreement with NAL, which includes a price ceiling of $900 per dmt. Our realized cost of sales was $805 per dmt in the three months ended September 30, 2023. Realized cost of sales is the average cost of sales including Piedmont’s offtake pricing agreement with NAL for the purchase of spodumene concentrate at a market price subject to a floor of $500 per metric ton and a ceiling of $900 per metric ton, with adjustments for product grade, freight, and insurance.
26
Exploration and Mine Development Costs
Exploration and mine development costs increased 8.5%, to $0.5 million in the three months ended September 30, 2023 compared to $0.4 million in the three months ended September 30, 2022. The change was primarily driven by an increase in exploration and engineering activities related to new project targets.
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased $4.0 million, or 56.2%, to $11.2 million in the three months ended September 30, 2023 compared to $7.2 million in the three months ended September 30, 2022. The increase in selling, general and administrative expenses was primarily due to increased professional fees, consulting services, and employee compensation costs related to the hiring of additional management and support staff at our headquarters in Belmont, North Carolina during 2023. Stock-based compensation expense included in selling, general and administrative expenses was $3.0 million and $1.1 million in the three months ended September 30, 2023 and 2022, respectively.
Income (Loss) from Equity Method Investments
Income from equity method investments increased $5.9 million, or 292.3%, to $3.9 million in the three months ended September 30, 2023 compared to loss from equity method investments of $2.0 million in the three months ended September 30, 2022. The current period income reflects our proportionate share of income resulting from our investment in Sayona Mining and their consolidated subsidiary Sayona Quebec. This income was partially offset by our proportionate share of net loss from Atlantic Lithium.
Other Income
Other income decreased $20.7 million, or 72.9%, to $9.0 million in the three months ended September 30, 2023 from $29.7 million in the three months ended September 30, 2022. The decrease was primarily due to our gain on dilution of equity method investments related to Sayona Mining of $8.0 million in the three months ended September 30, 2023, compared to $29.4 million in the three months ended September 30, 2022, which was partially offset by an increase in interest income of $0.7 million for the same comparable period.
Income Tax Expense
Income tax expense was $2.0 million in the three months ended September 30, 2023 compared to $3.4 million in the three months ended September 30, 2022. The decrease in income tax expense was primarily due to the decreased pre-tax impact of the gain on dilution in Sayona Mining for the same comparable period.
Nine Months Ended September 30, 2023 Compared to Nine Months Ended September 30, 2022
Nine Months Ended September 30, | |||||||||||||||||||||||
(in thousands) | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||
Revenue | $ | 47,127 | $ | — | $ | 47,127 | * | ||||||||||||||||
Costs of sales | 23,363 | — | 23,363 | * | |||||||||||||||||||
Gross profit | 23,764 | — | 23,764 | * | |||||||||||||||||||
Gross profit margin | 50.4 | % | — | % | |||||||||||||||||||
Exploration and mine development costs | 1,668 | 1,485 | 183 | 12.3% | |||||||||||||||||||
Selling, general and administrative expenses | 31,793 | 20,200 | 11,593 | 57.4% | |||||||||||||||||||
Total operating expenses | 33,461 | 21,685 | 11,776 | 54.3% | |||||||||||||||||||
Loss from equity method investments | (1,565) | (6,547) | 4,982 | (76.1)% | |||||||||||||||||||
Loss from operations | (11,262) | (28,232) | 16,970 | (60.1)% | |||||||||||||||||||
Other income | 18,045 | 29,583 | (11,538) | (39.0)% | |||||||||||||||||||
Income tax expense | 3,170 | 3,422 | (252) | (7.4)% | |||||||||||||||||||
Net income (loss) | $ | 3,613 | $ | (2,071) | $ | 5,684 | (274.5%) |
* Not meaningful.
27
Revenue
Revenue was $47.1 million in the nine months ended September 30, 2023 from the sale of 29,011 dmt of spodumene concentrate from our purchase offtake agreement with NAL. We had no sales in the nine months ended September 30, 2022. The realized price per dmt was $1,624 for the nine months ended September 30, 2023. Realized price is the average estimated price, net of certain distribution and other fees, for approximate 5.3% Li2O grade, which includes referenced pricing data up to September 30, 2023, and is subject to final adjustment. The final adjusted price may be higher or lower than the average estimated realized price based future market price movements. We have estimated the final sales pricing based on expected market conditions and known quality measurements. Any adjustments to the sales price will be reflected in subsequent periods.
Gross Profit and Gross Profit Margin
Gross profit was $23.8 million and gross profit margin was 50.4%, in the nine months ended September 30, 2023. Gross profit and gross profit margin were driven by our preferential offtake supply agreement with NAL, which includes a price ceiling of $900 per dmt. Our realized cost of sales was $805 per dmt in the nine months ended September 30, 2023. Realized cost of sales is the average cost of sales including Piedmont’s offtake pricing agreement with NAL for the purchase of spodumene concentrate at a market price subject to a floor of $500 per metric ton and a ceiling of $900 per metric ton, with adjustments for product grade, freight, and insurance.
Exploration and Mine Development Costs
Exploration and mine development costs increased $0.2 million, or 12.3%, to $1.7 million in the nine months ended September 30, 2023 compared to $1.5 million in the nine months ended September 30, 2022. The change was primarily driven by an increase in exploration and engineering activities related to new project targets.
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased $11.6 million, or 57.4%, to $31.8 million in the nine months ended September 30, 2023 compared to $20.2 million in the nine months ended September 30, 2022. The increase in selling, general and administrative expenses was primarily due to increased professional fees, consulting fees and increased employee compensation costs related to the hiring of additional management and support staff at our headquarters in Belmont, North Carolina during 2023. Stock-based compensation expense included in selling, general and administrative expenses was $7.3 million and $2.5 million in the nine months ended September 30, 2023 and 2022, respectively.
Loss from Equity Method Investments
Loss from equity method investments decreased $5.0 million, or 76.1%, to $1.6 million in the nine months ended September 30, 2023 compared to $6.5 million in the nine months ended September 30, 2022. The loss reflects our proportionate share of the net loss resulting from our investments in Sayona Mining, Sayona Quebec, and Atlantic Lithium. The change was driven by a decrease in losses from Sayona Quebec, Sayona Mining and Atlantic Lithium of $2.6 million, $1.5 million, $0.9 million, respectively.
Other Income
Other income decreased $11.5 million, or 39.0%, to $18.0 million in the nine months ended September 30, 2023 compared to $29.6 million in the nine months ended September 30, 2022. The decrease was primarily due to our gain on dilution of equity method investments related to Sayona Mining of $15.2 million in the nine months ended September 30, 2023 compared to $29.4 million in the nine months ended September 30, 2022 which was partially offset by an increase in interest income of $2.6 million during the same comparable period.
Income Tax Expense
Income tax expense was $3.2 million in the nine months ended September 30, 2023 compared to income tax expense of $3.4 million in the nine months ended September 30, 2022. The decrease in income tax expense was primarily due to the decreased pre-tax impacts of the gain on dilution in Sayona Mining in the same comparable period.
28
Liquidity and Capital Resources
Overview
As of September 30, 2023, we had cash and cash equivalents of $94.5 million compared to $99.2 million as of December 31, 2022. As of September 30, 2023, the vast majority of our cash balances were held in the U.S. A significant portion of our cash balances are covered by FDIC insured limits.
During three months ended September 30, 2023, we generated $25 million in cash from operations as we collected cash from a customer associated with a sale during the quarter. Our predominant source of cash to date has been generated through equity financing from issuances of our common stock. In February 2023, we issued 1,096,535 shares of our common stock at $68.40 per share to LG Chem for $75 million. We received cash proceeds of $71.1 million, which is net of $3.9 million in share issuance costs associated with the private placement. As of September 30, 2023, we had $369.2 million remaining under our shelf registration statement, which expires on September 24, 2024.
Our primary uses of cash during the nine months ended September 30, 2023 consisted of: (i) purchases of real property and associated mining interests of $22.5 million and exploration and development expenditures of $2.4 million associated with Carolina Lithium; (ii) equity investments in Sayona Quebec mainly for the operational restart of NAL totaling $28.1 million; (iii) capital expenditures primarily related to engineering costs of $20.0 million for Tennessee Lithium; and (iv) advances to Atlantic Lithium primarily for exploration and evaluation activities related to our investment in Ewoyaa totaling $6.9 million.
As of September 30, 2023, we had working capital of $79.3 million and long-term debt of less than $0.1 million, net of the current portion of $0.2 million, related to seller financed debt, as discussed above.
Liquidity Outlook
In the fourth quarter of 2023, we expect to receive provisional payments from customers for the shipment of approximately 27,500 dmt of spodumene concentrate. We expect pricing for these shipments to be based on spot-market pricing and the cost to be based on a price ceiling of $900 per dmt in accordance with our offtake agreement with NAL. We expect to fund capital expenditures totaling $18.0 million to $22.0 million primarily for Tennessee Lithium and Carolina Lithium and investments in and advances to affiliates totaling $10.0 million to $14.0 million in the fourth quarter of 2023. Investments in and advances to affiliates include cash contributions to our equity method investees and cash advances to Atlantic Lithium for the Ewoyaa Project.
During the third quarter, we engaged advisors to support our funding strategy for the construction of Tennessee Lithium. In consultation with the DOE, we have decided to pursue an ATVM loan under the DOE’s Loan Programs Office rather than complete the previously announced $141.7 million grant under the Bipartisan Infrastructure Law. We expect that the ATVM loan, if awarded, would cover a significantly larger share of the capital required for the project, thereby strengthening the opportunity for strategic parties to partner with us on the project. We are also in the process of submitting an ATVM loan application for Carolina Lithium. Construction is not planned to commence for either Tennessee Lithium or Carolina Lithium until project financing has been finalized for the respective project.
We plan to meet our liquidity needs through available cash balances and operating cash flows. Our planned cash expenditures for the next twelve months primarily relate to: (i) continued cash advances in strategic investments including Ewoyaa; (ii) real property acquisition costs and engineering activities associated with Tennessee Lithium; (iii) real property and associated mineral rights acquisition costs and continued permitting, engineering, and testing activities associated with Carolina Lithium; and (iv) working capital requirements.
Currently, there are no plans for future cash distributions from any of our equity method investments.
As of September 30, 2023, we had entered into land acquisition contracts in North Carolina and Tennessee totaling $35.0 million, of which we expect to close and fund $10.7 million in the fourth quarter of 2023, $19.8 million in 2024, and $4.5 million in 2025. These amounts do not include closing costs such as attorneys’ fees, taxes, and commissions. We are not obligated to exercise our land option agreements, and we are able to cancel our land acquisition contracts, at our option with de minimis cancellation costs, during the contract due diligence period. Certain land option agreements and land acquisition contracts become binding upon commencement of construction for Carolina Lithium.
29
We believe our current cash balances are sufficient to fund our cash requirements for at least the next 12 months. In the event costs were to exceed our planned expenditures, we will reduce or eliminate current and/or planned discretionary spending. If further reductions are required, we will reduce certain non-discretionary expenditures.
Historically, we have been successful raising cash through equity financing; however, no assurances can be given that additional financing will be available in amounts sufficient to meet our needs or on terms that are acceptable to us. If we issue additional shares of our common stock, it would result in dilution to our existing shareholders. There are many factors that could significantly impact our ability to raise funds through equity and debt financing as well as influence the timing of future cash flows. See Part II, Item 1A, “Risk Factors” in this Form 10-Q.
Cash Flows
The following table is a condensed schedule of cash flows provided as part of the discussion of liquidity and capital resources:
(in thousands) | Nine Months Ended September 30, | ||||||||||
Net cash provided by (used in): | 2023 | 2022 | |||||||||
Operating activities | $ | 5,403 | $ | (22,041) | |||||||
Investing activities | (80,473) | (45,794) | |||||||||
Financing activities | 70,318 | 121,179 | |||||||||
Net (decrease) increase in cash and cash equivalents | $ | (4,752) | $ | 53,344 |
Cash Flows from Operating Activities
Operating activities provided $5.4 million and used $22.0 million in the nine months ended September 30, 2023 and 2022, respectively, resulting in an increase in cash provided by operating activities of $27.4 million. The increase was primarily due to an increase in net income of $19.6 million after adjusting for certain noncash items, including gain on dilution, loss from equity method investments, stock compensation expense, and deferred taxes. Also contributing to the increase was a $7.9 million decrease in working capital.
Cash Flows from Investing Activities
Investing activities used $80.5 million and $45.8 million in the nine months ended September 30, 2023 and 2022, respectively, resulting in an increase in cash used in investing activities of $34.7 million. The increase was primarily due to an increase in investments in affiliates of $14.6 million primarily relating to Sayona Quebec for additional investments to fund the NAL restart. Also contributing to the increase was increased capital expenditures of $19.6 million and $3.4 million for Tennessee Lithium and Carolina Lithium, respectively. These increases were partially offset by a decrease in cash advances to our strategic lithium projects of $3.0 million for exploration and evaluation activities related to phase 1 of Ewoyaa.
Cash Flows from Financing Activities
Financing activities provided $70.3 million and $121.2 million in the nine months ended September 30, 2023 and 2022, respectively, resulting in a decrease in cash provided of $50.9 million. The decrease in cash from financing activities was mainly due to a $51.1 million decrease in net cash proceeds from issuances of our common stock and cash exercises of stock options in the nine months ended September 30, 2023 compared to September 30, 2022 as well as an increase in payments to tax authorities for employee share-based compensation of $0.4 million. This decrease in cash provided was partially offset by a decrease in debt payments totaling $0.6 million.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Other than the items listed below, there have been no material changes in our risk factors from those disclosed in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report for the year ended December 31, 2022.
The transportation industry is faced with economic inflation and possible recession. A prolonged period of inflation could result in increased interest rates, higher fuel prices, and decreased consumer spending, which could have a negative impact on our business and financial results. The results of these impacts could include supply chain instability, longer lead times, delayed orders, and continued issues with capacity constraints in driver, truck, and shipping container availability.
30
Since Russia’s invasion of Ukraine, global supply chains have experienced increased fuel prices. While we do not have direct exposure to these geographies, we cannot predict how global supply chain activities, or the economy at large may be impacted by a prolonged war in Ukraine or sanctions imposed in response to the war.
Item 4. Controls and Procedures.
Our management, under supervision and with the participation of our Chief Executive Officer (our Principal Executive Officer) and Chief Financial Officer (our Principal Financial Officer and Principal Accounting Officer), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of September 30, 2023. Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2023. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
Changes in Internal Control over Financial Reporting
During the three months ended September 30, 2023, we implemented new controls over revenue transactions accounted for under ASC 606, Revenue from Contracts with Customers. There were no other changes in internal control over financial reporting identified in the evaluation for the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
31
PART II - OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS.
Information regarding legal proceedings is contained in Note 12—Commitments and Contingencies of the unaudited consolidated financial statements contained in this report and is incorporated herein by reference.
Item 1A. RISK FACTORS.
Other than the items listed below, there have been no material changes in our risk factors from those disclosed in Part I, Item 1A, “Risk Factors” in our Annual Report for the year ended December 31, 2022.
Our cash and cash equivalents could be adversely effected if the financial institutions in which it holds its cash and cash equivalents fail.
We maintain cash deposits in accounts that, at times may exceed the amount of insurance provided on such deposits by the FDIC. If one or more of the financial institutions in which we hold cash deposits fails, we could lose all or a portion of our uninsured cash balances. If access to our cash accounts in the future is impaired, whether temporarily or otherwise, we may be unable to pay our operational expenses such as payroll or make other payments. There can be no assurance that the FDIC will take actions to support deposits in excess of existing FDIC insured limits. If banks and financial institutions enter receivership or become insolvent in the future, including the financial institutions in which we, our equity method investments, or our customers hold cash, our and their ability to access existing cash, cash equivalents, and investments may be threatened and could have a material adverse effect on our business and financial condition. In addition, there is a risk that one or more of our current service providers, financial institutions, and other partners may be adversely affected by the foregoing risks, which could directly affect our ability to conduct our business plans on schedule and on budget.
The planned Tennessee Lithium project will be dependent upon our ability to source spodumene concentrate feedstock to be converted to lithium hydroxide at the facility.
Tennessee Lithium will depend upon sourcing spodumene concentrate to produce lithium hydroxide. We intend to provide spodumene concentrate to Tennessee Lithium from our international assets, primarily Ewoyaa in Ghana. While we do not have reason to believe that spodumene concentrate from Ewoyaa would not be available, we expect there to be options available for exploring alternative sources to feed Tennessee Lithium, if needed, especially given the benefits of the Inflation Reduction Act for producers who supply the U.S. electric vehicle market. However, we cannot guarantee our ability to source spodumene concentrate, and our inability to do so would negatively impact our ability to produce lithium hydroxide in Tennessee.
The Company is dependent on a limited number of customers, which makes it vulnerable to the continued relationship with and financial health of those customers.
Two customers accounted for 100% of the Company’s sales in the three and nine months ended September 30, 2023. The Company’s future prospects may depend on the continued business of a limited number of key customers and on our continued status as a qualified supplier to such customers. The Company cannot guarantee that these key customers will continue to buy products from us at current levels. The loss of a key customer could have a material adverse effect on the Company’s unaudited consolidated financial statements.
Our long-term success depends on our ability to enter into and deliver product under offtake agreements.
We may encounter difficulty entering and fulfilling offtake agreements for our products. We may fail to deliver the product required by such agreements or may experience production costs in excess of the price to be paid to us under such agreements. Our current offtake agreements require us to deliver product meeting certain specifications, including quality thresholds related to chemical composition and grain size. Failure to meet these specifications could result in price adjustments, the rejection of deliveries or termination of the contracts. In addition, our supply agreements contain force majeure provisions allowing temporary suspension of performance by us or the customer during specified events beyond the control of the affected party. As a result of these issues, we may not achieve the revenue or profit we expect to achieve from our offtake agreements. As of the date of this filing, we have entered into two offtake agreements for our lithium products.
On January 2, 2023, we entered into an amended offtake agreement with Tesla to provide spodumene concentrate from NAL in Quebec. The agreement commits us to sell 125,000 metric tons of spodumene concentrate from our offtake agreement with Sayona
32
Quebec. The term of the agreement is three years, from the second half of 2023 until the end of 2025, and pricing is determined by a market-based mechanism. The three-year term can be extended for an additional three years upon mutual agreement.
On February 16, 2023, we entered into a spodumene concentrate offtake agreement with LG Chem. The agreement commits us to sell 200,000 metric tons of spodumene concentrate from our offtake agreement with Sayona Quebec. The term of the agreement is four years, beginning in the third quarter of 2023 until the third quarter of 2027 or until we have delivered 200,000 metric tons of spodumene concentrate. Pricing is determined by a market-based mechanism.
Our business, results of operations, and financial condition may be materially and adversely affected if we are unable to enter into similar agreements with other buyers, deliver the products required by such agreements, or incur costs in excess of the price set forth in such agreements.
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
None.
Item 3. DEFAULTS UPON SENIOR SECURITIES.
None.
Item 4. MINE SAFETY DISCLOSURES.
Not applicable because we do not currently operate any mines subject to the U.S. Federal Mine Safety and Health Act of 1977.
Item 5. OTHER INFORMATION.
On August 17, 2023, Keith Phillips, President and CEO, adopted a rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 30,000 shares of the Company’s common stock until November 29, 2024.
During the three months ended September 30, 2023, no other director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule10b5-1 trading arrangement,” as each term is defined in item 408(a) of Regulation S-K.
33
Item 6. EXHIBITS.
Exhibit Index
Exhibit Number | Description | ||||
Amended and Restated Certificate of Incorporation of Piedmont Lithium Inc. (filed with the SEC as Exhibit 3.1 to the Company’s Current Report on Form 8-K12B filed on May 18, 2021) | |||||
Amended and Restated Bylaws of Piedmont Lithium Inc. (filed with the SEC as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on February 24, 2023) | |||||
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||
Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||
Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||
Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||
101.INS* | XBRL Instance Document - - embedded within the Inline XBRL document | ||||
101.SCH* | XBRL Taxonomy Extension Schema Document | ||||
101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document | ||||
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | ||||
101.LAB* | XBRL Taxonomy Extension Label Linkbase Document | ||||
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document | ||||
104* | Cover page Interactive Data file (formatted as Inline XBRL and contained in Exhibit 101). |
__________________________
*Filed herewith.
34
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Piedmont Lithium Inc. | ||||||||
(Registrant) | ||||||||
Date: November 9, 2023 | By: | /s/ Michael White | ||||||
Michael White | ||||||||
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
35